Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- GKOS
- Price
- 90.07
- Stock movement up
- +0.41 (0.46%)
- Company name
- Glaukos Corp
- Exchange
- (NYSE ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 4.97B
- Ent value
- 5.12B
- Price/Sales
- 13.78
- Price/Book
- 7.43
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 49.95%
- 1 year return
- -9.67%
- 3 year return
- 14.20%
- 5 year return
- 24.16%
- 10 year return
- -
Last updated: 2025-04-11
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
GKOS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 13.78 |
| Price to Book | 7.43 |
| EV to Sales | 14.22 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 55.14M |
| EPS (TTM) | -2.72 |
| FCF per share (TTM) | -1.48 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 360.35M |
| Gross profit (TTM) | 276.06M |
| Operating income (TTM) | -118.09M |
| Net income (TTM) | -149.57M |
| EPS (TTM) | -2.72 |
| EPS (1y forward) | -1.11 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 76.61% |
| Operating margin (TTM) | -32.77% |
| Profit margin (TTM) | -41.51% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 100.14M |
| Net receivables | 56.41M |
| Total current assets | 397.28M |
| Goodwill | 66.13M |
| Intangible assets | 269.42M |
| Property, plant and equipment | 168.27M |
| Total assets | 926.54M |
| Accounts payable | 11.10M |
| Short/Current long term debt | 157.13M |
| Total current liabilities | 71.68M |
| Total liabilities | 258.03M |
| Shareholder's equity | 668.51M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -72.49M |
| Capital expenditures (TTM) | 8.78M |
| Free cash flow (TTM) | -81.27M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -22.37% |
| Return on Assets | -16.14% |
| Return on Invested Capital | -20.62% |
| Cash Return on Invested Capital | -11.21% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 89.66 |
| Daily high | 91.25 |
| Daily low | 86.31 |
| Daily Volume | 533K |
| All-time high | 161.22 |
| 1y analyst estimate | 146.83 |
| Beta | 1.03 |
| EPS (TTM) | -2.72 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 29 Apr 2025 |
Downside potential
Loading...
Downside potential data
| GKOS | S&P500 | |
| Current price drop from All-time high | -44.13% | -12.89% |
| Highest price drop | -69.57% | -56.47% |
| Date of highest drop | 20 Mar 2020 | 9 Mar 2009 |
| Avg drop from high | -26.78% | -11.07% |
| Avg time to new high | 23 days | 12 days |
| Max time to new high | 740 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
4.97B
Marketcap category
Mid-cap
Description
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Employees
907
Website
Investor relations
-
SEC filings
CEO
Thomas William Burns
Country
USA
City
San Clemente
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page